Literature DB >> 30363856

Spread of Muscle Spasms in Hemifacial Spasm.

Antonella Conte1,2, Marika Falla1, Maria Concetta Diana1, Matteo Bologna2, Antonio Suppa2, Andrea Fabbrini1, Carlo Colosimo1, Alfredo Berardelli1,2, Giovanni Fabbrini1,2.   

Abstract

Hemifacial spasm (HFS) is a clinical condition characterized by involuntary contractions in facial muscles. The aim of the study was to investigate, systematically in 178 patients with HFS, the frequency of spread from the site of origin to other facial muscles. Patients enrolled underwent a complete neurological examination and a face-to-face interview. Spread of the spasm to other facial muscles was considered to be present in those patients whose spasms onset in a single site and involved both upper and lower facial muscles at the time of examination. We also collected information about gender, age, age at HFS onset, symptom duration, muscles involved by the spasm at the time of onset, and spread of spasm to other facial muscles. Spread of spasms to the other facial muscles of the same side of the face was present in 93.4% of patients with HFS, and latency of spread was related to disease duration and age at onset. In patients with HFS, spread of muscle spasms represents the natural history of HFS.

Entities:  

Keywords:  hemifacial spasm; movement disorder; spread

Year:  2014        PMID: 30363856      PMCID: PMC6183182          DOI: 10.1002/mdc3.12106

Source DB:  PubMed          Journal:  Mov Disord Clin Pract        ISSN: 2330-1619


  14 in total

1.  Excitability of facial nucleus and related brain-stem reflexes in hemifacial spasm, post-facial palsy synkinesis and facial myokymia.

Authors:  A Emre Oge; Vildan Yayla; Gülşen Akman Demir; Mefkure Eraksoy
Journal:  Clin Neurophysiol       Date:  2005-07       Impact factor: 3.708

2.  Hemifacial spasm: difficulties in locating the lesion electrophysiologically.

Authors:  V K Nielsen; M J Soso; P J Jannetta
Journal:  Muscle Nerve       Date:  1984-10       Impact factor: 3.217

Review 3.  The many faces of hemifacial spasm: differential diagnosis of unilateral facial spasms.

Authors:  Toby C Yaltho; Joseph Jankovic
Journal:  Mov Disord       Date:  2011-04-05       Impact factor: 10.338

4.  Clinical assessment of patients with primary and postparalytic hemifacial spasm: a retrospective study.

Authors:  Andre Carvalho Felicio; Clecio de Oliveira Godeiro-Junior; Vanderci Borges; Sonia Maria de Azevedo Silva; Henrique Ballalai Ferraz
Journal:  Arq Neuropsiquiatr       Date:  2007-09       Impact factor: 1.420

5.  On the origin of synkinesis in hemifacial spasm: results of intracranial recordings.

Authors:  A R Møller; P J Jannetta
Journal:  J Neurosurg       Date:  1984-09       Impact factor: 5.115

6.  Facial nerve demyelination and vascular compression are both needed to induce facial hyperactivity: a study in rats.

Authors:  A Kuroki; A R Møller
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

7.  Hemifacial spasm: clinical findings and treatment.

Authors:  A Wang; J Jankovic
Journal:  Muscle Nerve       Date:  1998-12       Impact factor: 3.217

8.  Hemifacial spasm in Singapore: clinical characteristics and patients ' perceptions.

Authors:  W L Au; L C S Tan; A K Y Tan
Journal:  Ann Acad Med Singapore       Date:  2004-05       Impact factor: 2.473

9.  Anatomical study of the trigeminal and facial cranial nerves with the aid of 3.0-tesla magnetic resonance imaging.

Authors:  Yukinari Kakizawa; Tatsuya Seguchi; Kunihiko Kodama; Toshihiro Ogiwara; Tetsuo Sasaki; Tetsuya Goto; Kazuhiro Hongo
Journal:  J Neurosurg       Date:  2008-03       Impact factor: 5.115

Review 10.  Electrodiagnostic studies of the facial nerve in peripheral facial palsy and hemifacial spasm.

Authors:  Josep Valls-Solé
Journal:  Muscle Nerve       Date:  2007-07       Impact factor: 3.217

View more
  1 in total

1.  Hemifacial spasm is not affected by state of consciousness: a case report.

Authors:  Tao Li; Zhuo Feng; Chunli Song; Zhanhua Liang
Journal:  Eur J Med Res       Date:  2021-12-07       Impact factor: 2.175

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.